A series of novel 2H-pyrazolo[4,3-c]hexahydropyridine derivatives (II) have been designed and synthesized. The target compounds have been identified by elemental analysis and spectral ( 1 H NMR, IR, and MS) data and t...A series of novel 2H-pyrazolo[4,3-c]hexahydropyridine derivatives (II) have been designed and synthesized. The target compounds have been identified by elemental analysis and spectral ( 1 H NMR, IR, and MS) data and the absolute configuration of compound (II 1 ) was confirmed by single crystal X-ray diffraction. The cytotoxicity of the target compounds have been evalu- ated in vitro against two human breast cancer cell lines MCF-7 and MDA-MB-231 by MTT assay. Most compounds exhibited good inhibition, and compounds II 21 (IC 50=4.7μM for MCF-7 and IC 50=9.3μM for MDA-MB-231), II 33 (IC 50=2.4μM for MCF-7 and IC 50=4.2μM for MDA-MB-231) and II 40 (IC 50=3.3μM for MCF-7 and IC 50 =8.6μM for MDA-MB-231) displayed better inhibitory activity than 5-fluorouracil (IC 50=4.8μM for MCF-7 and IC 50=9.6μM for MDA-MB-231, respectively). Flow cytometric analysis and DNA fragmentation suggest that II 33 is cytotoxic and able to induce the apoptosis of MCF-7 cells. The fluorescence properties of compounds II 1 , II 6 , II 11 , II 16 , II 23 , II 28, and II 35 were also studied and compound II 28 afforded the highest photoluminescence quantum yield (38%).展开更多
基金supported by Zooblast-molecular Biology Laboratory of Shanghai Normal Universitysupported by the National Natural Science Foundation of China (21042010, 21102092 and30870560)+4 种基金the Key Scientific "Twelfth Five-Year" National Technology Support Program (2011BAE06B01-17)the Innovation Project of Shanghai Education Commission (12YZ078)the Key Project of the Science and Technology Commission of Shanghai 105405503400)the Leading Academic Discipline Project of Shanghai Normal University (DZL808)Shanghai Key Laboratory of Rare Earth Functional Materials, Shanghai Normal University (07dz22303)
文摘A series of novel 2H-pyrazolo[4,3-c]hexahydropyridine derivatives (II) have been designed and synthesized. The target compounds have been identified by elemental analysis and spectral ( 1 H NMR, IR, and MS) data and the absolute configuration of compound (II 1 ) was confirmed by single crystal X-ray diffraction. The cytotoxicity of the target compounds have been evalu- ated in vitro against two human breast cancer cell lines MCF-7 and MDA-MB-231 by MTT assay. Most compounds exhibited good inhibition, and compounds II 21 (IC 50=4.7μM for MCF-7 and IC 50=9.3μM for MDA-MB-231), II 33 (IC 50=2.4μM for MCF-7 and IC 50=4.2μM for MDA-MB-231) and II 40 (IC 50=3.3μM for MCF-7 and IC 50 =8.6μM for MDA-MB-231) displayed better inhibitory activity than 5-fluorouracil (IC 50=4.8μM for MCF-7 and IC 50=9.6μM for MDA-MB-231, respectively). Flow cytometric analysis and DNA fragmentation suggest that II 33 is cytotoxic and able to induce the apoptosis of MCF-7 cells. The fluorescence properties of compounds II 1 , II 6 , II 11 , II 16 , II 23 , II 28, and II 35 were also studied and compound II 28 afforded the highest photoluminescence quantum yield (38%).